Lymph Node Ratio Is an Independent Prognostic Factor After Resection of Periampullary Malignancies: Data From a Tertiary Referral Center in the Middle East

Objective:The prognostic impact of nodal involvement in resected pancreatic carcinoma and biliary malignancy has been relatively well established. It has been suggested that lymph node ratio (LNR) may be a more informative way of stratifying patients with node positive disease. Our retrospective review aimed to investigate the significance of such variables and test for independent prognostic factors for survival. Methods:One hundred eighty-three pancreatic and periampullary malignancy cases were registered at the American University of Beirut Medical Center from 1990 to 2004. Of those, 80 had complete data on lymph node status. We analyzed the impact of the number of lymph nodes resected, the number of positive lymph nodes retrieved and LNR using Kaplan-Meier and Cox proportional hazard models. The measured outcome in the KM model was the survival probability at 1, 3, and 5 years while the Cox model was used to measure the hazard ratio (HR) of the previously identified predictors on survival. Results:For the 80 patients included in this analysis, overall survival rates were 65% (54 to 78), 32% (18 to 47), and 21% (8 to 34) were alive at 1, 3, and 5 years, respectively. The median number of resected lymph nodes was 9. In the node positive patients, those who had >12 nodes examined were found to have a significantly better survival (HR=0.24; P=0.013). On multivariate analysis, our model showed the following factors to be significant: age 60 years or older (HR=5.92; P=0.018), poorly differentiated tumors (HR=21.87; P=0.018), number of lymph nodes examined <12 LN (HR=6.77; P=0.022), 3 or more metastatic LN (HR=7.21; P=0.028), and LNR≥0.2 (HR=7.12; P=0.007). Conclusions:After pancreaticodudonectomy for adenocarcinoma of the pancreas and biliary malignancies, ratio-based lymph node staging is an independent and powerful prognostic factor.

[1]  Matthew Z. Wilson,et al.  Prognostic significance of lymph node metastases and ratio in esophageal cancer. , 2008, The Journal of surgical research.

[2]  A. Nakao,et al.  Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  D. Lorenz,et al.  Long-term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25-Year Experience , 2003, World Journal of Surgery.

[4]  J. Wisnivesky,et al.  Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer , 2011, Cancer.

[5]  H. Riediger,et al.  Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection , 2006, Journal of Gastrointestinal Surgery.

[6]  S. Mocellin,et al.  The Ratio Between Metastatic and Examined Lymph Nodes (N Ratio) Is an Independent Prognostic Factor in Gastric Cancer Regardless of the Type of Lymphadenectomy: Results From an Italian Multicentric Study in 1853 Patients , 2007, Annals of surgery.

[7]  P. Pattyn,et al.  Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic Review , 2010, Annals of surgical oncology.

[8]  K. Campbell,et al.  Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival, Morbidity, and Mortality , 2002, Annals of surgery.

[9]  F. Jamali,et al.  Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer , 2010, Indian journal of surgical oncology.

[10]  M. Choti,et al.  Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. , 2007, Surgery.

[11]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[12]  E. Ross,et al.  The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma , 2004, The American surgeon.

[13]  C. Earle,et al.  Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients , 2003, Annals of surgery.

[14]  I. Endo,et al.  Prognostic Factors After Resection of Pancreatic Cancer , 2008, World Journal of Surgery.

[15]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[16]  M. Sierzega,et al.  The Ratio of Metastatic/Resected Lymph Nodes is an Independent Prognostic Factor in Patients With Node-positive Pancreatic Head Cancer , 2006, Pancreas.

[17]  M. Gönen,et al.  Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer , 2007, Journal of Gastrointestinal Surgery.

[18]  G. Ohshio,et al.  Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas , 1989, Cancer.

[19]  O. Ishikawa,et al.  Practical Usefulness of Lymphatic and Connective Tissue Clearance for the Carcinoma of the Pancreas Head , 1988, Annals of surgery.

[20]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[21]  Michael A. Choti,et al.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience , 2006, Journal of Gastrointestinal Surgery.

[22]  K. Dhaene,et al.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. , 1998, Annals of surgery.